Skip to main navigation
Skip to main content
Opthea Limited, Inc Logo
  • Home
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Stock Info
    Stock Quote Stock Chart Historical Stock Quote Analysts
  • ASX Filings
  • SEC Filings
  • Reports
  • Resources
    Investor FAQs Investor Email Alerts Contact Us

ASX Filings

Appendix 2A Update
October 21, 2021
Becoming a substantial holder
October 21, 2021
Cleansing Notice
October 21, 2021
Results of Meeting
October 19, 2021
Opthea Corporate Presentation - October 2021
October 19, 2021
Opthea Opens Patient Enrollment in the Asia-Pacific Region for the OPT-302 ShORe and COAST Phase 3 Trials in Wet AMD
October 19, 2021
Additional Formats
PDF Version
Opthea Chairman's Address to the 2021 Annual General Meeting
October 19, 2021
Ceasing to be a substantial holder
October 11, 2021
Opthea Opens Patient Recruitment in Europe for Pivotal Phase 3 ShORe and COAST Wet AMD Trials of OPT-302
October 4, 2021
Additional Formats
PDF Version
Change in substantial holding
October 1, 2021
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 31
  • Page 32
  • Current page 33
  • Page 34
  • Page 35
  • …
  • Next page ›
  • Last page »
Displaying 321 - 330 of 658

If you wish to receive email alerts on company news, please sign up below:

  • © Opthea Limited, Inc 2024